Parallel Advisors, LLC Argenx Se Transaction History

Parallel Advisors, LLC

$4.31 Billion
Q1 2025

A detailed history of Parallel Advisors, LLC transactions in Argenx Se stock. As of the latest transaction made, Parallel Advisors, LLC holds 627 shares of ARGX stock, worth $385,454. This represents 0.01% of its overall portfolio holdings.

Number of Shares

627

Previous 676 7.25%

Holding current value

$385,454

Previous $415,000 10.6%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	SELL	$571.0 - $671.75 $27,979 - $32,915	-49 Reduced 7.25%	627 $371,000
Q4 2024 Feb 10, 2025	BUY	$520.52 - $638.33 $39,559 - $48,513	76 Added 12.67%	676 $415,000
Q3 2024 Nov 13, 2024	BUY	$434.22 - $551.9 $24,750 - $31,458	57 Added 10.5%	600 $325,000
Q2 2024 Aug 08, 2024	BUY	$356.01 - $451.55 $2,848 - $3,612	8 Added 1.5%	543 $233,000
Q1 2024 May 06, 2024	BUY	$356.95 - $413.29 $51,043 - $59,100	143 Added 36.48%	535 $210,000
Q4 2023 Feb 09, 2024	SELL	$338.91 - $506.01 $26,773 - $39,974	-79 Reduced 16.77%	392 $149,000
Q3 2023 May 20, 2024	BUY	$369.35 - $548.43 $7,387 - $10,968	20 Added 4.43%	471 $231,000
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $7,387 - $10,968	20 Added 4.43%	471 $231,000
Q2 2023 May 20, 2024	BUY	$360.14 - $422.58 $4,321 - $5,070	12 Added 2.73%	451 $175,000
Q2 2023 Aug 04, 2023	BUY	$360.14 - $422.58 $4,321 - $5,070	12 Added 2.73%	451 $175,000
Q1 2023 May 20, 2024	SELL	$334.23 - $403.65 $32,086 - $38,750	-96 Reduced 17.94%	439 $163,000
Q1 2023 Apr 25, 2023	BUY	$334.23 - $403.65 $3,008 - $3,632	9 Added 2.09%	439 $163,000
Q4 2022 Feb 03, 2023	BUY	$342.17 - $402.31 $12,660 - $14,885	37 Added 9.41%	430 $162,000
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $19,219 - $22,162	56 Added 16.62%	393 $139,000
Q2 2022 Aug 01, 2022	BUY	$269.58 - $378.88 $11,052 - $15,534	41 Added 13.85%	337 $128,000
Q1 2022 Apr 28, 2022	SELL	$254.45 - $351.06 $22,137 - $30,542	-87 Reduced 22.72%	296 $93,000
Q4 2021 Jan 20, 2022	BUY	$272.01 - $353.03 $67,730 - $87,904	249 Added 185.82%	383 $134,000
Q3 2021 Nov 02, 2021	BUY	$295.0 - $350.58 $23,305 - $27,695	79 Added 143.64%	134 $40,000
Q2 2021 Aug 06, 2021	SELL	$257.11 - $319.92 $2,056 - $2,559	-8 Reduced 12.7%	55 $17,000
Q1 2021 Apr 23, 2021	BUY	$268.3 - $380.31 $10,463 - $14,832	39 Added 162.5%	63 $17,000
Q4 2020 Feb 02, 2021	BUY	$248.13 - $308.36 $3,970 - $4,933	16 Added 200.0%	24 $7,000
Q3 2020 Oct 27, 2020	BUY	$215.51 - $272.51 $1,724 - $2,180	8 New	8 $2,000
Q2 2020 Jul 16, 2020	SELL	$127.44 - $232.72 $7,773 - $14,195	-61 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$108.83 - $165.23 $6,638 - $10,079	61 New	61 $8,000

Others Institutions Holding ARGX

# of Institutions

445

Shares Held

29.1M

Call Options Held

390K

Put Options Held

272K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Argenx Se Transaction History